Lanean...

Medical Treatment of Benign Prostatic Hyperplasia

Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly impro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Lepor, Herbert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MedReviews, LLC 2011
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3151584/
https://ncbi.nlm.nih.gov/pubmed/21826125
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!